Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$396K Sell
3,085
-1,049
-25% -$123K 0.12% 122
2026
Q1
$497K Sell
4,134
-53
-1% -$6.12K 0.17% 106
2025
Q4
$441K Buy
+4,187
New +$393K 0.15% 111

Other funds holding MRK

TMB Capital Partners's MRK Position: Q2 2026 in Review

TMB Capital Partners reduced its Merck (MRK) stake by 25% in Q2 2026, selling an estimated $123K and leaving 3,085 shares worth $396K. The position accounts for 0.12% of the portfolio, ranked #122.

TMB Capital Partners first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $497K in Q1 2026. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • TMB Capital Partners held 3,085 shares of Merck worth $396K as of Q2 2026.
  • TMB Capital Partners sold 1,049 Merck shares in Q2 2026, an estimated $123K.
  • Merck made up 0.12% of TMB Capital Partners's portfolio in Q2 2026, its #122 holding.
  • TMB Capital Partners first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • TMB Capital Partners's Merck position peaked at $497K in Q1 2026.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on TMB Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.